multiple sclerosis progression

Disease activity increases after multiple sclerosis patients stop drug

harminka — Thu, 13 Sep 2007 07:12:26 -0500

People with multiple sclerosis who stop taking the drug natalizumab may experience a rebound increase in disease activity, according to a study published September 12, 2007, in the online edition of Neurology®, the medical journal of the American Academy of Neurology.

New light on multiple sclerosis disease progression

harminka — Tue, 28 Aug 2007 06:04:05 -0500

Using magnetic resonance (MR) images of the brain, researchers have identified a new abnormality related to disease progression and disability in patients with multiple sclerosis (MS), according to a study published in the August issue of Radiology.

New imaging approach promises insights into multiple sclerosis

harminka — Wed, 18 Apr 2007 06:35:35 -0500

Researchers have developed a way to use three types of microscopic imaging techniques simultaneously to analyze living tissue and learn more about the molecular mechanisms of multiple sclerosis, information that could help lead to earlier detection and new treatments.

Multiple sclerosis patients not receiving medications to slow disease progression

harminka — Mon, 16 Apr 2007 12:22:38 -0500

Neurologists at Wake Forest University Baptist Medical Center have found that many patients diagnosed with multiple sclerosis (MS) are not taking or being prescribed drugs approved to treat the disease.